PacBio Reports Director Changes and Executive Appointments
Ticker: PACB · Form: 8-K · Filed: Jun 6, 2025 · CIK: 1299130
Sentiment: neutral
Topics: management-change, governance, filing
Related Tickers: PACB
TL;DR
PacBio's board is shaking up: new directors elected, execs appointed, and compensation plans updated.
AI Summary
Pacific Biosciences of California, Inc. (PacBio) filed an 8-K on June 6, 2025, reporting on several key events that occurred on June 4, 2025. These include the departure of a director, the election of new directors, the appointment of certain officers, and the adoption of new compensatory arrangements. The filing also covers the submission of matters to a vote of security holders and includes financial statements and exhibits.
Why It Matters
Changes in board composition and executive appointments can signal shifts in company strategy or governance, potentially impacting future performance and investor confidence.
Risk Assessment
Risk Level: medium — Changes in leadership and governance can introduce uncertainty, but the filing also indicates routine corporate actions like shareholder votes and financial reporting.
Key Numbers
- 001-34899 — Commission File Number (Identifies the SEC filing for the company.)
- 16-1590339 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Pacific Biosciences of California, Inc. (company) — Registrant
- June 4, 2025 (date) — Date of earliest event reported
- June 6, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of incorporation
- 1305 O'Brien Drive (address) — Principal executive office address
- Menlo Park, California 94025 (address) — Principal executive office location
FAQ
Who departed from the board of directors of Pacific Biosciences of California, Inc.?
The filing indicates the departure of a director, but the specific name is not provided in the excerpt.
When were the new directors elected and officers appointed?
The earliest event reported, including the election of directors and appointment of officers, occurred on June 4, 2025.
What is the principal executive office address of Pacific Biosciences of California, Inc.?
The principal executive office is located at 1305 O'Brien Drive, Menlo Park, California 94025.
What is the Commission File Number for Pacific Biosciences of California, Inc.?
The Commission File Number is 001-34899.
What types of compensatory arrangements were adopted?
The filing mentions the adoption of compensatory arrangements for certain officers, but the specific details of these arrangements are not included in the provided excerpt.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 6, 2025 regarding PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB).